Advisory on Safety of COX-2 Inhibitors

Ask AI

BFAD BUREAU CIRCULAR NO. 8, S. 2005: Advisory on Safety of COX-2 Inhibitors

Getting related questions...
What do you want to know about the law?
Your conversations and searches stay on your device. We do not store or track your activity on our servers. To know more about our privacy commitment see jur.ph/privacy Ask AI provides quick answers grounded in full case texts to avoid mistakes. Always verify with the original text.

Ask AI

Title Supreme Court: Advisory on Safety of COX-2 Inhibitors

Law: Bfad Bureau Circular No. 8, S. 2005

Decision Date: Apr 4, 2005

The BFAD Bureau Circular No. 8, S. 2005 mandates black box warnings for cardiovascular risks associated with selective COX-2 inhibitors, advises healthcare providers on prescribing precautions, and emphasizes patient safety measures for those at risk of heart-related events.

administrative law

public safety

drug regulation

END